Patient Access 2021

Pricing and Policy

This final session of our conference, chaired by Steve Beard, Chief Consulting Officer who was joined by industry experts tackled the following topics: VPAS – what you need to know, commercial and managed access in England. This session concluded with a talk from Christian Hill, Chief Executive Officer, and co-founder of MAP, on ATMPs and responding to the new high cost / high value drugs.
MAP Patient Access Conference 2021 Session 4: Pricing and Policy

This final session of our conference, chaired by Steve Beard, Chief Consulting Officer who was joined by industry experts tackled the following topics: VPAS – what you need to know, commercial and managed access in England. This session concluded with a talk from Christian Hill, Chief Executive Officer, and co-founder of MAP, on ATMPs and responding to the new high cost / high value drugs.

Speakers

Christian Hill, Chief Executive Officer, MAP

Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.

Steve Beard, Chief Consulting Officer, MAP

Steve joined MAP in 2021 after 8 years at BresMed, where he was part of the executive management team developing and growing the business (from 25 staff to close to 200 staff at the end of 2020). It was Steve’s role to provide leadership of the day-to-day consultancy operations, covering the five technical delivery teams. Previously, Steve held a Chief Business Development Officer role, with a specific brief to develop the project pipeline and internal processes for scoping and bidding on projects. Steve also spent 13 years at RTI Health Solutions, as a Global Head and VP of Health Economics (Europe), after originally starting his Health Economic adventure at ScHARR, University of Sheffield, in the late 1990’s.

David Watson, Director Pricing and Reimbursement, ABPI

David Watson is currently the interim Executive Director, Economic, Health and Commercial Policy at the ABPI. David was previously the ABPI Commercial Policy Director leading on the Voluntary Scheme. David joined the ABPI in May 2014 from a consulting background and prior to that spent many years at Pfizer where he held a series of roles including European Head of Business Intelligence, channel strategy, and a variety of sales and marketing positions in the UK and the Pfizer European business.

David Thomson, Associate Director, Commercial Liaison, NICE


Speakers:

Christian Hill


Christian Hill, Chief Executive Officer, MAP

Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.

Steve Beard


Steve Beard, Chief Consulting Officer, MAP

[coming soon]

David Watson


David Watson, Director Pricing and Reimbursement, ABPI

David Watson is currently the interim Executive Director, Economic, Health and Commercial Policy at the ABPI. David was previously the ABPI Commercial Policy Director leading on the Voluntary Scheme. David joined the ABPI in May 2014 from a consulting background and prior to that spent many years at Pfizer where he held a series of roles including European Head of Business Intelligence, channel strategy, and a variety of sales and marketing positions in the UK and the Pfizer European business.

David Thomson


David Thomson, Associate Director, Commercial Liaison, NICE

[coming soon]

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52